icrf 198 has been researched along with nadp in 1 studies
Studies (icrf 198) | Trials (icrf 198) | Recent Studies (post-2010) (icrf 198) | Studies (nadp) | Trials (nadp) | Recent Studies (post-2010) (nadp) |
---|---|---|---|---|---|
24 | 0 | 4 | 21,608 | 25 | 3,484 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vile, GF; Winterbourn, CC | 1 |
1 other study(ies) available for icrf 198 and nadp
Article | Year |
---|---|
dl-N,N'-dicarboxamidomethyl-N,N'-dicarboxymethyl-1,2-diaminopropane (ICRF-198) and d-1,2-bis(3,5-dioxopiperazine-1-yl)propane (ICRF-187) inhibition of Fe3+ reduction, lipid peroxidation, and CaATPase inactivation in heart microsomes exposed to adriamycin.
Topics: Animals; Calcium-Transporting ATPases; Chelating Agents; Cytochrome c Group; Doxorubicin; Ethylenediamines; Ferric Compounds; Glycine; Kinetics; Lipid Peroxidation; Microsomes; Myocardium; NADP; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Piperazines; Rabbits; Razoxane; Stereoisomerism | 1990 |